Advertisement

Topics

Novel Agent S-1 Has Similar Efficacy to 5-FU in Certain Gastric Cancers

21:38 EDT 9 Aug 2017 | Cancer Networks

Results of a phase III trial suggest that the combination of the contemporary oral fluoropyrimidine S-1 and cisplatin offers similar efficacy to 5-flourouracil and cisplatin in patients with chemotherapy-naive diffuse type adenocarcinoma of the gastroesophageal junction or stomach.

Original Article: Novel Agent S-1 Has Similar Efficacy to 5-FU in Certain Gastric Cancers

NEXT ARTICLE

More From BioPortfolio on "Novel Agent S-1 Has Similar Efficacy to 5-FU in Certain Gastric Cancers"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...